Ivermectin Price Trend, Index and Forecast

Track the latest insights on ivermectin price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.

Ivermectin Prices Outlook Q4 2025

• USA: USD 157870/MT
• China: USD 128473/MT
• Germany: USD 145610/MT
• India: USD 148680/MT
• Brazil: USD 148883/MT

Ivermectin Price Chart

Get real-time access to monthly/quarterly/yearly prices Request Sample

During the fourth quarter of 2025, the ivermectin prices in the USA reached 157870 USD/MT in December. Prices increased supported by steady demand from veterinary pharmaceutical manufacturers and structured healthcare procurement channels. Additionally, regulated production standards and contract-based distribution frameworks influenced supply positioning, while buyers aligned sourcing with institutional purchasing cycles. During the fourth quarter of 2025, the ivermectin prices in China reached 128473 USD/MT in December. Prices declined as export-oriented bulk API demand softened and downstream formulation activity moderated. Moreover, competitive supplier positioning and sufficient domestic production capacity shaped procurement behavior, encouraging buyers to limit purchases to confirmed manufacturing schedules. During the fourth quarter of 2025, the ivermectin prices in Germany reached 145610 USD/MT in December. Prices moved lower influenced by moderated demand from pharmaceutical formulation facilities and cautious hospital procurement activity. Furthermore, structured distributor inventories and regulatory compliance processes shaped sourcing decisions across the healthcare supply chain. During the fourth quarter of 2025, the ivermectin prices in India reached 148680 USD/MT in December. Prices decreased driven by reduced export orders and competitive pricing among active pharmaceutical ingredient producers. In addition to this, stable raw material availability and disciplined inventory management influenced procurement strategies aligned with short-term production visibility. During the fourth quarter of 2025, the ivermectin prices in Brazil reached 148883 USD/MT in December. Prices edged lower amid moderated demand from domestic pharmaceutical manufacturers and structured public healthcare tenders. Apart from this, import dependency and logistics coordination influenced sourcing behavior, with buyers focusing on maintaining operational continuity.

Ivermectin Prices Outlook Q3 2025

• USA: USD 154260/MT
• China: USD 132912/MT
• Germany: USD 148916/MT
• India: USD 151560/MT
• Brazil: USD 153330/MT

During the third quarter of 2025, the ivermectin prices in the USA reached 154260 USD/MT in September. Prices moved upward as demand from pharmaceutical formulation units and veterinary medicine manufacturers improved. Increased procurement for regulated markets supported buying activity. Buyers aligned sourcing with production schedules and compliance requirements, while steady availability influenced purchasing strategies. During the third quarter of 2025, the ivermectin prices in China reached 132912 USD/MT in September. Prices declined due to softer export demand and sufficient domestic supply. Reduced overseas orders influenced procurement volumes, leading buyers to prioritize inventory optimization. Purchasing activity focused on short-term operational needs rather than forward commitments. During the third quarter of 2025, the ivermectin prices in Germany reached 148916 USD/MT in September. Prices moved downward as demand from pharmaceutical distributors and formulation units moderated. Inventory drawdowns and cautious procurement behavior influenced sourcing decisions. Buyers emphasized meeting immediate formulation requirements while managing compliance and documentation needs. During the third quarter of 2025, the ivermectin prices in India reached 151560 USD/MT in September. Prices increased as demand from export-oriented pharmaceutical manufacturers and domestic formulation units strengthened. Higher offtake for regulated and semi-regulated markets supported procurement. Buyers coordinated sourcing with production planning and regulatory timelines. During the third quarter of 2025, the ivermectin prices in Brazil reached 153330 USD/MT in September. Prices declined amid reduced procurement from veterinary medicine manufacturers and pharmaceutical distributors. Adequate import availability and cautious buying behavior influenced sourcing decisions. Buyers limited purchases to near-term operational requirements.

Ivermectin Prices Outlook Q2 2025

• USA: USD 150500/MT
• China: USD 135900/MT
• Germany: USD 152465/MT
• India: USD 147720/MT
• Brazil: USD 159985/MT

During the second quarter of 2025, the ivermectin prices in the USA reached 150500 USD/MT in June. Demand from pharmaceutical formulation and veterinary medicine segments influenced procurement activity. Buyers aligned sourcing with production schedules and inventory planning. During the second quarter of 2025, the ivermectin prices in China reached 135900 USD/MT in June. Consumption from export-oriented API manufacturing shaped procurement patterns. Domestic production capacity and inventory availability supported material access. During the second quarter of 2025, the ivermectin prices in Germany reached 152465 USD/MT in June. Demand from pharmaceutical distributors and formulation units guided sourcing decisions. Buyers coordinated procurement with regulatory compliance and batch documentation requirements. During the second quarter of 2025, the ivermectin prices in India reached 147720 USD/MT in June. Procurement was influenced by export demand and domestic formulation requirements. Buyers structured sourcing around confirmed manufacturing schedules. During the second quarter of 2025, the ivermectin prices in Brazil reached 159985 USD/MT in June. Demand from veterinary medicine producers and pharmaceutical distributors shaped procurement volumes. Import availability and logistics considerations influenced sourcing timelines.

Regional Coverage

The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the ivermectin prices.

Europe Ivermectin Price Trend

Q4 2025:

As per the ivermectin price index, European prices moved downward influenced by softened demand from pharmaceutical formulation plants and moderated procurement by institutional healthcare systems. Additionally, distributor-level inventory adjustments and regulatory compliance requirements shaped regional supply conditions. Buyers emphasized cautious purchasing aligned with confirmed production schedules and national tender frameworks across the healthcare sector.

Q3 2025:

Europe experienced downward price movement, influenced by declines observed in Germany. Moderated demand from pharmaceutical distributors and formulation units reduced regional consumption. Buyers relied on existing inventories and long-term supply agreements, limiting fresh procurement activity. Regulatory compliance, batch release requirements, and documentation timelines influenced sourcing decisions. Import availability supported supply continuity, with procurement aligned closely to confirmed formulation schedules rather than forward inventory accumulation.

Q2 2025:

In Europe, ivermectin demand was shaped by routine pharmaceutical formulation activity and distributor-led sourcing. Buyers coordinated procurement with production planning, regulatory documentation, and quality assurance requirements. Import availability and established logistics networks supported material access. Purchasing strategies emphasized specification compliance, traceability, and uninterrupted supply for ongoing pharmaceutical manufacturing operations. This analysis can be extended to include detailed ivermectin price information for a comprehensive list of countries.

Region	Countries Covered
Europe	Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries.

North America Ivermectin Price Trend

Q4 2025:

As per the ivermectin price index, prices in North America rose, supported by steady demand from veterinary pharmaceutical manufacturers and healthcare distributors. Furthermore, structured contract procurement and regulated production standards influenced supply positioning. Buyers maintained long-term sourcing agreements to ensure continuity across institutional and retail pharmaceutical channels.

Q3 2025:

North America experienced upward price movement, driven by increases in the USA. Improved demand from pharmaceutical formulation units and veterinary medicine manufacturers supported consumption. Buyers advanced procurement to meet production schedules and regulatory requirements. Domestic distribution networks and import availability supported supply continuity, while sourcing decisions focused on meeting confirmed demand rather than expanding inventory positions.

Q2 2025:

In North America, ivermectin demand reflected procurement aligned with pharmaceutical formulation schedules and veterinary medicine production. Buyers coordinated sourcing with inventory management and compliance documentation. Import flows and established supplier relationships supported material availability, while procurement strategies focused on maintaining uninterrupted access for regulated manufacturing. Specific ivermectin historical data within the United States and Canada can also be provided.

Region	Countries Covered
North America	United States and Canada

Middle East and Africa Ivermectin Price Trend

Q4 2025:

As per ivermectin price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.

Q3 2025:

The report explores the ivermectin pricing trends and ivermectin price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices. In addition to region-wise data, information on ivermectin prices for countries can also be provided.

Region	Countries Covered
Middle East & Africa	Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries.

Asia Pacific Ivermectin Price Trend

Q4 2025:

Across Asia Pacific, ivermectin prices moved downward influenced by softened export demand from major API manufacturing hubs and competitive supplier pricing. Moreover, stable domestic production capacity and moderated formulation activity shaped supply dynamics. Buyers adjusted procurement volumes conservatively, prioritizing short-term manufacturing visibility and inventory optimization.

Q3 2025:

Asia Pacific exhibited mixed price movement, with upward momentum in India and downward pressure in China. Strong demand from Indian export-oriented pharmaceutical manufacturers supported regional consumption, while softer export orders reduced Chinese offtake. Buyers adjusted sourcing strategies based on country-specific demand visibility and regulatory destination requirements. Domestic production capacity and regional trade flows supported material availability across key manufacturing hubs.

Q2 2025:

In Asia Pacific, ivermectin demand was shaped by pharmaceutical formulation activity across China and India. Buyers coordinated procurement with production planning, export order schedules, and compliance documentation requirements. Domestic supply availability and regional trade supported continuity, while procurement strategies emphasized operational alignment and batch traceability. This ivermectin price analysis can be expanded to include a comprehensive list of countries within the region.

Region	Countries Covered
Asia Pacific	China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries.

Latin America Ivermectin Price Trend

Q4 2025:

Regional market assessments across Latin America indicated a downward pricing trend for ivermectin supported by moderated domestic pharmaceutical demand and structured public healthcare tenders. Additionally, import reliance and distributor inventory management influenced procurement planning, with buyers aligning sourcing decisions to confirmed treatment program requirements.

Q3 2025:

Ivermectin prices in Latin America moved downward, led by declines in Brazil. Reduced procurement from veterinary medicine manufacturers and cautious distributor purchasing softened regional consumption. Buyers limited sourcing volumes amid inventory optimization efforts. Import availability supported supply, allowing procurement to remain closely aligned with confirmed formulation and veterinary supply requirements.

Q2 2025:

In Latin America, ivermectin procurement reflected demand from veterinary medicine producers and pharmaceutical distributors. Buyers scheduled sourcing based on confirmed supply commitments and inventory planning. Import flows and logistics coordination supported material availability, while procurement strategies focused on ensuring continuity of supply for regulated pharmaceutical and veterinary use. This comprehensive review can be extended to include specific countries within the region.

Region	Countries Covered
Latin America	Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries.

Ivermectin Pricing Report, Market Analysis, and News

IMARC's latest publication, “Ivermectin Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2026 Edition,” presents a detailed examination of the ivermectin market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of ivermectin at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed ivermectin prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting ivermectin pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comไprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.

Ivermectin Industry Analysis

The global ivermectin industry size reached USD 341.3 Million in 2025. By 2034, IMARC Group expects the market to reach USD 524.6 Million, at a projected CAGR of 4.89% d🌊uring 2026-2034. Market growth is driven by continued demand for antiparasitic medications, rising veterinary healthcare needs, expanding pharmaceutical manufacturing capacity, and sustained usage of ivermectin across regulated human and animal health applications worldwide.

Latest News and Developments:

• July 2025: A collaborative research study published in “The New England Journal of Medicine” found that mass drug administration of ivermectin reduced malaria transmission by about 26% in coastal Kenya, offering evidence for its potential role in global malaria control strategies. This trial involved investigators from the Barcelona Institute for Global Health (ISGlobal), the KEMRI-Wellcome Trust Research Program, and the Manhiça Health Research Centre, and suggests that ivermectin could complement existing mosquito control measures in high-transmission settings.

Product Description

Ivermectin refers to a broad-spectrum anti-parasitic agent derived from the avermectin family of compounds. It is extensively used in veterinary and human medicines to treat different parasitic infections. In veterinary medicine, it is widely utilized to control parasites in pets, horses, and livestock targeting gastrointestinal worms, lice, mites, and lungworms. Ivermectin is also employed in beekeeping and aquaculture to manage parasitic infestations. In humans, it is majorly used to combat diseases like lymphatic filariasis, onchocerciasis (river blindness), scabies, and strongyloidiasis. It works by binding to and disrupting the nervous system of parasites, leading to their paralysis and death. It also gained attention during the outbreak of the COVID-19 pandemic for its potential antiviral properties. The versatility, safety profile, and efficacy of ivermectin make it a vital tool in managing parasitic diseases across different sectors.

Report Coverage

Key Attributes	Details
Product Name	Ivermectin
Report Features	Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Ivermectin Price Analysis, and Segment-Wise Assessment.
Currency/Units	US$ (Data can also be provided in local currency) or Metric Tons
Region/Countries Covered	The current coverage includes analysis at the global and regional levels only.    Based on your requirements, we can also customize the report and provide specific information for the following countries:    Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*   Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece*    North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client.
Information Covered for Key Suppliers	Company Overview Business Description Recent Trends and Developments
Customization Scope	The report can be customized as per the requirements of the customer
Report Price and Purchase Option	Plan A: Monthly Updates - Annual Subscription Scope Historical Data for the Current Month Forecast for Next Month Total Deliverables Per Year: 12 (One Per Month) Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year Plan B: Quarterly Updates - Annual Subscription Scope Historical Data for the Current Quarter Forecast for Next Quarter Total Deliverables Per Year: 4 (One Per Quarter) Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year Plan C: Biannually Updates - Annual Subscription Scope Historical Data for the Current Half Forecast for the Next Half Total Deliverables Per Year: 2 (One Per 6 Months) Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
Post-Sale Analyst Support	360-degree analyst support after report delivery
Delivery Format	PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of ivermectin pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting ivermectin price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The ivermectin price charts ensure our clients remain at the forefront of the industry.